These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5766457)

  • 1. Aminoglutethimide in functioning adrenal carcinoma: case report.
    Kumar RS; Kamitsuna S; Cole VW
    South Med J; 1969 Feb; 62(2):225-7. PubMed ID: 5766457
    [No Abstract]   [Full Text] [Related]  

  • 2. Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    Horký K; Küchel O; Gregorvá I; Stárka L
    J Clin Endocrinol Metab; 1969 Feb; 29(2):297-9. PubMed ID: 4236926
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
    Smilo RP; Earll JM; Forsham PH
    Metabolism; 1967 Apr; 16(4):374-7. PubMed ID: 4290376
    [No Abstract]   [Full Text] [Related]  

  • 4. Amino-glutethimide (elipten) in adenocortical carcinoma.
    Miranda-Zetterstrand N; Díaz-Bonet L; Pagán-Sáez H; Rosaly de Jirau W
    Bol Asoc Med P R; 1968 Dec; 60(12):611-8. PubMed ID: 5253414
    [No Abstract]   [Full Text] [Related]  

  • 5. Excretion patterns of urinary 17-KS and 17-OHCS in patients with Cushing's syndrome.
    Mizutani S; Sonoda T; Seki T; Matsumoto K
    Urol Int; 1974; 29(5):341-50. PubMed ID: 4276760
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of aminoglutethimide on urinary steroid excretion in patients with congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency.
    Horký K; Kuchel O; Gregorová I; Stárka L
    Metabolism; 1972 Apr; 21(4):305-12. PubMed ID: 4334310
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F; Lloyd HM; Roeser HP; Thomas MJ
    Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of elipten in Itsenko-Cushing disease (preliminary report)].
    Marova EI; Lemesheva SN
    Probl Endokrinol (Mosk); 1970; 16(5):7-10. PubMed ID: 5520275
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of neutral urinary steroid analysis by gas liquid chromatography using OV-210].
    Horumon To Rinsho; 1971 Nov; 19(11):915-21. PubMed ID: 5169770
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration.
    Faglia G; Gattinoni L; Travaglini P; Neri V; Acerbi L; Ambrosi B
    Metabolism; 1971 Mar; 20(3):266-72. PubMed ID: 5546922
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M; Laudat MH; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with aminoglutethimide (Elipten), a new inhibitor of steroid biosynthesis in the adrenal gland].
    Horký K; Küchel O; Gregorová I; Jiránková J; Matys Z
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1843-51. PubMed ID: 4236505
    [No Abstract]   [Full Text] [Related]  

  • 13. CUSHING'S SYNDROME WITH HYPOGLYCEMIA CAUSED BY ADRENOCORTICAL CARCINOMA.
    EYMONTT MJ; GWINUP G; KRUGER FA; MAYNARD DE; HAMWI GJ
    J Clin Endocrinol Metab; 1965 Jan; 25():46-52. PubMed ID: 14252287
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibitions of steroid biosynthesis in the adrenal gland by aminogluthetimide (Elipten CIBA) and its practical significance].
    Horký K; Küchel O; Gregorová I; Jiránková J; Matys Z
    Vnitr Lek; 1969 May; 15(5):417-25. PubMed ID: 5792533
    [No Abstract]   [Full Text] [Related]  

  • 15. [Corticosteroidogenesis inhibitors. II. A new cortico-adrenal inhibitor: amino-glutethimide (16,038Ba)].
    Philbert M; Luton JP; Mathieu de Fossey B; Bricaire H
    Presse Med (1893); 1968 May; 76(23):1107-10. PubMed ID: 5657304
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of aminoglutethimide on extraglandular metabolism of exogenous testosterone.
    Horky K; Kuchel O; Stárka L; Gregorová I
    Metabolism; 1971 Mar; 20(3):331-6. PubMed ID: 4251108
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroid metabolism in premature pubarche and virilizing adrenal hyperplasia.
    Conly PW; Sandberg DH; Cleveland WW
    J Pediatr; 1967 Oct; 71(4):506-11. PubMed ID: 4227700
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of d-2(p-aminophenyl)-2-phenylethylamine (SK&F-12185) in Cushing's syndrome associated with adrenocortical carcinoma.
    Gabrilove JL; Nicolis GL; Gallagher TF
    Metabolism; 1968 Oct; 17(10):936-42. PubMed ID: 4877990
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary steroid-excretion patterns after acute myocardial infarction.
    Rao LG
    Lancet; 1970 Aug; 2(7669):390-1. PubMed ID: 4194693
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of response to adrenalectomy in the treatment of advanced breast cancer.
    Masnyk IJ; Silverman DT; Hankey BF
    J Natl Cancer Inst; 1978 Feb; 60(2):271-8. PubMed ID: 621745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.